Tech Spotlight: Using Nanotechnology to Treat Ear & Hearing Disorders: Interview with Otomagnetics CEO, Abhita Batra
This Week in Hearing
English - September 23, 2021 13:00 - 16 minutes - 15.3 MB - ★★★★★ - 1 ratingScience Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
In this week's technology spotlight, Dr. Bob Traynor speaks with Abhita Batra, CEO and Director of Otomagnetics. The company, a University of Maryland College Park spin-out, is developing a non-invasive method to deliver drugs and other therapeutic payloads to inner and middle ear compartments, to the eye, and into the skin.
The inner ear is behind the blood-labyrinth barrier – vessels that supply blood to the inner ear have walls that are impermeable to most drug molecules, and thus it is a challenge to deliver therapy to treat inner ear diseases. Otomagnetics is developing and commercializing a magnetic injection delivery system that will be able to safely, effectively, and non-invasively deliver therapy to targets in the body that are currently not effectively reached by the standards-of-care, or that may otherwise require surgery to reach.